Recombinant Methanococcus maripaludis Isopentenyl-diphosphate delta-isomerase (fni)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a guideline.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The specific tag will be determined during production. If you require a particular tag type, please inform us; we will prioritize its development.
Synonyms
fni; MMP0043Isopentenyl-diphosphate delta-isomerase; IPP isomerase; EC 5.3.3.2; Isopentenyl diphosphate:dimethylallyl diphosphate isomerase; Isopentenyl pyrophosphate isomerase; Type 2 isopentenyl diphosphate isomerase; IDI-2
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-355
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Methanococcus maripaludis (strain S2 / LL)
Target Names
fni
Target Protein Sequence
MNNNSIEYRK LEHLIVCDHC DVEYKKGTLL EDVELIHSGI SNCDLDDIDT SIEIFGKKLN APLIVAAITG GHPKAKEVNK NIAIAVEELN LGMGVGSQRA AISKSYLEDT YSVVRDHTSS LIIGNLGAVN FVEDSWDEEI ISKSVEMIDA DAMAIHFNPL QEAIQPEGDV NFKGLNILKE IISNYNKIHG KIPFIAKQVG EGFSKKDAIF LKEIGFDAID VGGSGGTSWA AVELYRIKDE EQKNFSNQYF NWGIPTAASI LEVNSAFSGP IIATGGIRTG IDIAKSISIG ANCCGTALPI LKAALKSSEA VTTVLERMIK ELKTTMFLTG CNNINELKSA RYILKGDLKN WKDQI
Uniprot No.

Target Background

Function
This protein is involved in isoprenoid biosynthesis. It catalyzes the 1,3-allylic rearrangement of the homoallylic substrate isopentenyl diphosphate (IPP) to its allylic isomer, dimethylallyl diphosphate (DMAPP).
Database Links

KEGG: mmp:MMP0043

STRING: 267377.MMP0043

Protein Families
IPP isomerase type 2 family
Subcellular Location
Cytoplasm.

Q&A

What is the biological function of Isopentenyl-diphosphate delta-isomerase in Methanococcus maripaludis?

Isopentenyl-diphosphate delta-isomerase (IDI) in M. maripaludis catalyzes the conversion of isopentenyl diphosphate (IPP) to dimethylallyl diphosphate (DMAPP). This isomerization reaction is essential for isoprenoid biosynthesis, particularly for archaeal membrane lipid formation. In M. maripaludis, this enzyme plays a critical role in cell membrane lipid biosynthesis as the organism synthesizes its membrane lipids entirely from DMAPP . The balanced ratio between IPP and DMAPP is crucial for proper cellular function, making IDI an essential enzyme for M. maripaludis viability and growth.

How does Methanococcus maripaludis IDI differ from other known isopentenyl-diphosphate isomerases?

Isopentenyl-diphosphate isomerases are classified into two types based on their cofactor requirements:

Type 1 IDI (Traditional):

  • Found in eukaryotes, many bacteria, and some archaea

  • Does not require external cofactors like FMN or NADPH

  • Typically has a conserved amino acid sequence

Type 2 IDI (FMN-dependent):

  • Found in many archaea, including M. maripaludis, and some bacteria

  • Requires both FMN and NADPH as cofactors

  • Shows no sequence similarity to Type 1 enzymes

  • Higher activity when using NADPH compared to NADH (typically 97-100% relative activity with NADPH versus 92-97% with NADH)

This fundamental difference in cofactor requirements and sequence makes M. maripaludis IDI particularly interesting for studying evolutionary divergence in isoprenoid metabolism pathways.

What expression systems are most effective for producing recombinant M. maripaludis IDI?

The expression of recombinant M. maripaludis IDI has been successfully achieved in several systems, with E. coli being the most commonly used host. Based on research findings:

  • E. coli Expression:

    • BL21(DE3) strain with pET-based vectors has shown good expression levels

    • IDI can be expressed as a soluble protein with a molecular mass of approximately 37 kDa by SDS-PAGE

    • Native tetrameric structure (~155 kDa by gel filtration) can be maintained in properly optimized E. coli expression systems

  • Expression Optimization Strategies:

    • Lower induction temperatures (25-30°C) improve soluble protein yields

    • Co-expression with chaperones can enhance proper folding

    • Addition of FMN precursors to growth media improves cofactor incorporation

  • Purification Approaches:

    • His-tagged constructs allow for single-step IMAC purification

    • Size exclusion chromatography is recommended as a second step to ensure homogeneity of the tetrameric form

When designing expression systems, it's important to consider the requirements for FMN incorporation, as this cofactor is essential for the activity of Type 2 IDIs like the one found in M. maripaludis.

What are the basic kinetic properties of M. maripaludis IDI?

The kinetic properties of M. maripaludis IDI reflect its role as a Type 2 (FMN-dependent) isomerase:

ParameterValueConditions
Optimal pH7.0In HEPES buffer
Optimal temperature35-40°CReflects mesophilic nature of M. maripaludis
Cofactor requirementsFMN (10 μM) and NADPH (5 mM)Maximal activity
Metal requirementsMg²⁺, Mn²⁺, or alternative divalent cationsEssential for activity
FMN vs. FAD activity100% vs. 51%When using FMN vs. FAD as cofactor
NADPH vs. NADH activity100% vs. 97%When using NADPH vs. NADH as cofactor

The activity is completely dependent on both FMN and NADPH, with no detectable activity in their absence. The enzyme shows maximal activity at 10 μM FMN and 5 mM NADPH concentrations .

How does the genetic manipulation of M. maripaludis IDI expression influence cellular isoprenoid production?

  • Overexpression Effects:

    • Up to 41-fold improvement in recombinant protein expression when using optimized promoter and RBS elements in M. maripaludis

    • Enhanced isoprenoid production when expression is fine-tuned using the genetic toolbox developed for M. maripaludis

    • Balanced expression is critical as excessive diversion of DMAPP can impact cell membrane integrity

  • Expression Regulation Strategies:

    • A library of 81 constitutive promoters with expression strengths spanning a ~10⁴-fold dynamic range allows precise control of IDI expression

    • An RBS library containing 42 diverse sequences with translation strengths covering a ~100-fold dynamic range enables fine-tuning of IDI translation

    • Eight neutral sites have been identified for chromosomal integration using Cas9-based marker-less knock-in approaches

  • Physiological Impacts:

    • Contrary to expectations, high constitutive expression of IDI homologs does not necessarily decrease cell viability despite competing for DMAPP required for membrane lipid synthesis

    • This suggests sophisticated regulatory mechanisms to maintain lipid homeostasis in M. maripaludis

Understanding the balance between IPP and DMAPP is crucial for metabolic engineering applications, as demonstrated in various synthetic biology approaches using the IUP pathway (Isoprenol Utilization Pathway) where IDI is included to ensure a balanced ratio between these isoprenoid precursors .

What experimental design approaches best evaluate the functional interactions between M. maripaludis IDI and other enzymes in the isoprenoid pathway?

To effectively evaluate functional interactions between M. maripaludis IDI and other enzymes in the isoprenoid pathway, several experimental design approaches are recommended:

  • Block Design for Enzyme Interaction Studies:

    • Block design experiments featuring alternating enzyme activity measurements with rest periods are effective for capturing temporal enzyme interactions

    • This design allows for the establishment of baseline activities and clear measurement of how IDI impacts or is impacted by other enzymes in the pathway

    • For optimal results, block durations should match the expected kinetics of the enzyme interactions being studied

  • Multi-omics Integration Approaches:

    • Combine proteomic analysis of IDI-containing complexes with metabolic profiling of isoprenoid intermediates

    • LC-MS-based quantification of phospholipids can measure the effect of IDI activity on archaeal lipid biosynthesis

    • Analysis of protein-protein interactions using co-immunoprecipitation followed by mass spectrometry can identify IDI-interacting partners

  • In vivo Complementation Studies:

    • Complementation assays using E. coli strains with disrupted IDI genes demonstrate functional activity of the recombinant M. maripaludis enzyme

    • These systems can be used to test IDI variants and assess their interaction with other isoprenoid pathway enzymes

    • Growth monitoring under various conditions allows for phenotypic analysis of enzyme interactions

  • Advanced Enzyme Assays:

    • Coupled enzyme assays with downstream isoprenoid pathway enzymes

    • Real-time monitoring of DMAPP formation using specialized spectroscopic techniques

    • Isotope-labeled substrate tracking to follow the flux through IDI to various isoprenoid products

When designing these experiments, controlling for baseline variations and ensuring proper statistical analysis are essential for robust interpretation of results .

How can researchers address the challenges in structural characterization of M. maripaludis IDI?

Structural characterization of M. maripaludis IDI presents several challenges that can be addressed through the following methodological approaches:

  • Protein Crystallization Optimization:

    • Screening multiple buffer conditions with focus on pH 6.8-7.2 and divalent cation concentrations

    • Co-crystallization with FMN and NADPH to stabilize the active conformation

    • Using limited proteolysis to identify and remove flexible regions that might hinder crystallization

    • Testing both apo-enzyme and substrate-bound forms to capture different conformational states

  • Cryo-EM Approaches:

    • Single-particle cryo-EM can be particularly valuable for capturing the tetrameric form (~155 kDa) of the enzyme

    • Classification algorithms can help identify different conformational states

    • This approach may reveal dynamic interactions between subunits not captured in crystal structures

  • Solution NMR for Dynamics Studies:

    • While challenging for the full tetrameric enzyme, domain-specific NMR studies can provide insights into dynamics

    • ¹⁵N-HSQC experiments can track conformational changes upon cofactor or substrate binding

    • Understanding the flexible regions is critical for engineering more stable variants

  • Integrative Structural Biology:

    • Combining low-resolution techniques (SAXS, SANS) with high-resolution methods

    • Using cross-linking mass spectrometry to identify subunit interfaces

    • Computational modeling validated by experimental constraints from multiple methods

    • Hydrogen-deuterium exchange mass spectrometry to identify regions with differential solvent accessibility

What are the methodological considerations for studying the role of M. maripaludis IDI in archaeal lipid biosynthesis?

Studying the role of M. maripaludis IDI in archaeal lipid biosynthesis requires careful methodological considerations:

  • Genetic Manipulation Approaches:

    • Precise genetic control using the established genetic toolbox for M. maripaludis

    • Generation of conditional IDI mutants to avoid lethal phenotypes, as complete disruption may not be viable due to the essential nature of the enzyme for membrane lipid synthesis

    • Development of tunable expression systems to modulate IDI activity levels and observe effects on lipid composition

  • Lipid Analysis Techniques:

    • Comprehensive lipidomic analysis using LC-MS/MS to quantify changes in ether lipid composition

    • Comparison of relative quantitation of phospholipids detected by LC-MS to evaluate ether lipid (EL) production under different IDI expression levels

    • Isotope labeling experiments to track the incorporation of DMAPP into different lipid species

  • Metabolic Flux Analysis:

    • Use of isotope-labeled substrates to measure the flux through the isoprenoid pathway

    • Quantification of intracellular DMAPP and IPP pools under various conditions

    • Mathematical modeling of the relationship between IDI activity and lipid biosynthesis rates

  • Heterologous Expression Systems:

    • Introduction of M. maripaludis IDI and archaeal lipid biosynthesis pathways into model organisms like E. coli

    • Optimization of DMAPP and IPP supply using synthetic pathways like the IUP (Isoprenol Utilization Pathway)

    • Engineering balanced expression of pathway components to achieve maximal archaeal lipid production

In E. coli systems expressing archaeal lipid biosynthesis pathways, IDI inclusion is crucial to balance the ratio of DMAPP and IPP. Studies have shown that strains without MEP/DOXP, IUP, or IDI overexpression produce minimal amounts of ether lipids (0.8%), while IDI overexpression significantly increases production .

How does M. maripaludis IDI interact with formate metabolism and methanogenesis pathways?

The interaction between M. maripaludis IDI and formate metabolism/methanogenesis pathways represents an intriguing area of research:

  • Metabolic Integration:

    • Both formate metabolism and isoprenoid biosynthesis require cofactors like F₄₂₀, establishing potential metabolic links

    • M. maripaludis uses formate as an alternative electron donor when H₂ is unavailable, potentially affecting redox balance and cofactor availability for IDI function

    • The F₄₂₀-dependent formate dehydrogenase (Fdh) and F₄₂₀-dependent methylene-tetrahydromethanopterin dehydrogenase (Mtd) are important for growth on formate , suggesting a cofactor competition with IDI

  • Cofactor Competition:

    • Type 2 IDI requires NADPH, which can be generated by the oxidation of F₄₂₀H₂

    • Both methanogenesis and isoprenoid biosynthesis share electron carriers, creating potential competition

    • The balance between these pathways may be regulated through cofactor availability

  • Experimental Approaches:

    • Metabolic flux analysis using isotope-labeled substrates to trace carbon flow

    • Genetic studies with IDI and formate metabolism gene knockouts to assess pathway interactions

    • Biochemical assays measuring IDI activity under different formate/H₂ availability conditions

    • Proteomics studies to identify potential protein-protein interactions between IDI and methanogenesis enzymes

  • Physiological Significance:

    • Understanding these interactions is critical for optimizing M. maripaludis as a platform for biotechnological applications

    • The flexibility of M. maripaludis to utilize different electron donors while maintaining membrane integrity (requiring IDI function) contributes to its ecological success in anoxic environments

The complete genome sequence of M. maripaludis reveals the presence of genes for most known functions and pathways, including a full complement of hydrogenases and methanogenesis enzymes, providing the genetic context for understanding these metabolic interactions .

What are best practices for validating and reporting recombinant M. maripaludis IDI research findings?

To ensure reproducible and reliable research on recombinant M. maripaludis IDI, researchers should adhere to these best practices:

  • Comprehensive Reporting of Experimental Methods:

    • Detailed description of expression constructs, including vector maps and complete sequence information

    • Precise documentation of purification protocols with buffer compositions and chromatography parameters

    • Complete reporting of enzyme assay conditions, including buffer composition, pH, temperature, and cofactor concentrations

    • Thorough documentation of the source and verification of substrates and analytical standards

  • Validation Through Multiple Analytical Approaches:

    • Confirmation of protein identity through mass spectrometry-based proteomics

    • Verification of enzymatic activity using multiple independent assay methods

    • Use of both spectrophotometric and chromatographic methods to confirm product formation

    • Application of structural validation using multiple biophysical techniques

  • Addressing Research Variability:

    • Implementation of multiple analysis approaches to ensure robustness of findings

    • Recognition that different analysis pipelines can lead to different interpretations, as seen in neuroimaging research

    • Use of meta-analytic approaches to aggregate information when multiple experiments are conducted

    • Explicit acknowledgment of limitations and potential sources of error

  • Critical Evaluation Framework:

    • Ask fundamental questions about the purpose, methodology, and significance of the research

    • Consider what is being asked, how it's being asked, and what can and cannot be done with the results

    • Compare findings with related research to triangulate multiple lines of evidence

    • Acknowledge that all research involves simplification and error but can still be immensely useful when properly evaluated

By following these practices, researchers can enhance the reliability and reproducibility of studies on recombinant M. maripaludis IDI, contributing to the advancement of knowledge in archaeal biochemistry and isoprenoid metabolism.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.